Corbus Pharmaceuticals Holdings, Inc.
CRBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | -85.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -6,164.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -5,166.4% |
| EPS Diluted | -3.68 | -10.31 | -10.15 | -11.11 |
| % Growth | 64.3% | -1.6% | 8.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |